TY - JOUR
T1 - International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis
T2 - Consensus From an International Working Group
AU - Oude Voshaar, Martijn A. H.
AU - Das Gupta, Zofia
AU - Bijlsma, Johannes W. J.
AU - Boonen, Annelies
AU - Chau, Jeffrey
AU - Courvoisier, Delphine S.
AU - Curtis, Jeffrey R.
AU - Ellis, Benjamin
AU - Ernestam, Sofia
AU - Gossec, Laure
AU - Hale, Christine
AU - Hornjeff, Jennifer
AU - Leung, Katy Y. Y.
AU - Lidar, Merav
AU - Mease, Phillip
AU - Michaud, Kaleb
AU - Mody, Girish M.
AU - Ndosi, Mwidimi
AU - Opava, Christina H.
AU - Pinheiro, Geraldo R. C.
AU - Salt, Matthew
AU - Soriano, Enrique R.
AU - Taylor, William J.
AU - Voshaar, Maria J. H.
AU - Weel, Angelique E. A. M.
AU - de Wit, Maarten
AU - Wulffraat, Nico
AU - van de Laar, Mart A. F. J.
AU - Vonkeman, Harald E.
N1 - Publisher Copyright:
© 2018, The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.
PY - 2019/12
Y1 - 2019/12
N2 - Objective The implementation of value-based health care in inflammatory arthritis requires a standardized set of modifiable outcomes and risk-adjustment variables that is feasible to implement worldwide. Methods The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary working group that consisted of 24 experts from 6 continents, including 6 patient representatives, to develop a standard set of outcomes for inflammatory arthritis. The process followed a structured approach, using a modified Delphi process to reach consensus on the following decision areas: conditions covered by the set, outcome domains, outcome measures, and risk-adjustment variables. Consensus in areas 2 to 4 were supported by systematic literature reviews and consultation of experts. Results The ICHOM Inflammatory Arthritis Standard Set covers patients with rheumatoid arthritis (RA), axial spondyloarthritis, psoriatic arthritis, and juvenile idiopathic arthritis (JIA). We recommend that outcomes regarding pain, fatigue, activity limitations, overall physical and mental health impact, work/school/housework ability and productivity, disease activity, and serious adverse events be collected at least annually. Validated measures for patient-reported outcomes were endorsed and linked to common reporting metrics. Age, sex at birth, education level, smoking status, comorbidities, time since diagnosis, and rheumatoid factor and anti-citrullinated protein antibody lab testing for RA and JIA should be collected as risk-adjustment variables. Conclusion We present the ICHOM inflammatory arthritis Standard Set of outcomes, which enables health care providers to implement the value-based health care framework and compare outcomes that are important to patients with inflammatory arthritis.
AB - Objective The implementation of value-based health care in inflammatory arthritis requires a standardized set of modifiable outcomes and risk-adjustment variables that is feasible to implement worldwide. Methods The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary working group that consisted of 24 experts from 6 continents, including 6 patient representatives, to develop a standard set of outcomes for inflammatory arthritis. The process followed a structured approach, using a modified Delphi process to reach consensus on the following decision areas: conditions covered by the set, outcome domains, outcome measures, and risk-adjustment variables. Consensus in areas 2 to 4 were supported by systematic literature reviews and consultation of experts. Results The ICHOM Inflammatory Arthritis Standard Set covers patients with rheumatoid arthritis (RA), axial spondyloarthritis, psoriatic arthritis, and juvenile idiopathic arthritis (JIA). We recommend that outcomes regarding pain, fatigue, activity limitations, overall physical and mental health impact, work/school/housework ability and productivity, disease activity, and serious adverse events be collected at least annually. Validated measures for patient-reported outcomes were endorsed and linked to common reporting metrics. Age, sex at birth, education level, smoking status, comorbidities, time since diagnosis, and rheumatoid factor and anti-citrullinated protein antibody lab testing for RA and JIA should be collected as risk-adjustment variables. Conclusion We present the ICHOM inflammatory arthritis Standard Set of outcomes, which enables health care providers to implement the value-based health care framework and compare outcomes that are important to patients with inflammatory arthritis.
KW - PATIENT-CENTERED OUTCOMES
KW - TREATING RHEUMATOID-ARTHRITIS
KW - SYSTEMATIC LITERATURE SEARCH
KW - STANDARD SET
KW - CORE SET
KW - DISEASE
KW - RECOMMENDATIONS
KW - MANAGEMENT
KW - QUALITY
KW - CANCER
U2 - 10.1002/acr.23799
DO - 10.1002/acr.23799
M3 - Article
SN - 2151-464X
VL - 71
SP - 1556
EP - 1565
JO - Arthritis Care & Research
JF - Arthritis Care & Research
IS - 12
ER -